Serum fibroblast growth factor 19 (FGF19) levels are associated with atherogenic dyslipidemia in patients with type 2 diabetes

Serum fibroblast growth factor 19 (FGF19) levels are associated with atherogenic dyslipidemia in patients with type 2 diabetes

Bibliographic Details
Main Authors: Jing-Yi Hu, Hai-Lan Zou, Yan-Hua Li, Dong-Ying Nie, Chen Chao, Jin-Han Liu, Jin Ding, Zhi-Guang Zhou, Yang Xiao, Ning-Ning Wang
Format: Article
Language:English
Published: Wolters Kluwer 2021-09-01
Series:Chinese Medical Journal
Online Access:http://journals.lww.com/10.1097/CM9.0000000000001574
id doaj-37ed5ad32cec4d87abb6f3206b1986ca
record_format Article
spelling doaj-37ed5ad32cec4d87abb6f3206b1986ca2021-09-28T10:18:44ZengWolters KluwerChinese Medical Journal0366-69992542-56412021-09-01134182243224510.1097/CM9.0000000000001574202109200-00016Serum fibroblast growth factor 19 (FGF19) levels are associated with atherogenic dyslipidemia in patients with type 2 diabetesJing-Yi HuHai-Lan ZouYan-Hua LiDong-Ying NieChen ChaoJin-Han LiuJin DingZhi-Guang ZhouYang XiaoNing-Ning Wanghttp://journals.lww.com/10.1097/CM9.0000000000001574
collection DOAJ
language English
format Article
sources DOAJ
author Jing-Yi Hu
Hai-Lan Zou
Yan-Hua Li
Dong-Ying Nie
Chen Chao
Jin-Han Liu
Jin Ding
Zhi-Guang Zhou
Yang Xiao
Ning-Ning Wang
spellingShingle Jing-Yi Hu
Hai-Lan Zou
Yan-Hua Li
Dong-Ying Nie
Chen Chao
Jin-Han Liu
Jin Ding
Zhi-Guang Zhou
Yang Xiao
Ning-Ning Wang
Serum fibroblast growth factor 19 (FGF19) levels are associated with atherogenic dyslipidemia in patients with type 2 diabetes
Chinese Medical Journal
author_facet Jing-Yi Hu
Hai-Lan Zou
Yan-Hua Li
Dong-Ying Nie
Chen Chao
Jin-Han Liu
Jin Ding
Zhi-Guang Zhou
Yang Xiao
Ning-Ning Wang
author_sort Jing-Yi Hu
title Serum fibroblast growth factor 19 (FGF19) levels are associated with atherogenic dyslipidemia in patients with type 2 diabetes
title_short Serum fibroblast growth factor 19 (FGF19) levels are associated with atherogenic dyslipidemia in patients with type 2 diabetes
title_full Serum fibroblast growth factor 19 (FGF19) levels are associated with atherogenic dyslipidemia in patients with type 2 diabetes
title_fullStr Serum fibroblast growth factor 19 (FGF19) levels are associated with atherogenic dyslipidemia in patients with type 2 diabetes
title_full_unstemmed Serum fibroblast growth factor 19 (FGF19) levels are associated with atherogenic dyslipidemia in patients with type 2 diabetes
title_sort serum fibroblast growth factor 19 (fgf19) levels are associated with atherogenic dyslipidemia in patients with type 2 diabetes
publisher Wolters Kluwer
series Chinese Medical Journal
issn 0366-6999
2542-5641
publishDate 2021-09-01
url http://journals.lww.com/10.1097/CM9.0000000000001574
work_keys_str_mv AT jingyihu serumfibroblastgrowthfactor19fgf19levelsareassociatedwithatherogenicdyslipidemiainpatientswithtype2diabetes
AT hailanzou serumfibroblastgrowthfactor19fgf19levelsareassociatedwithatherogenicdyslipidemiainpatientswithtype2diabetes
AT yanhuali serumfibroblastgrowthfactor19fgf19levelsareassociatedwithatherogenicdyslipidemiainpatientswithtype2diabetes
AT dongyingnie serumfibroblastgrowthfactor19fgf19levelsareassociatedwithatherogenicdyslipidemiainpatientswithtype2diabetes
AT chenchao serumfibroblastgrowthfactor19fgf19levelsareassociatedwithatherogenicdyslipidemiainpatientswithtype2diabetes
AT jinhanliu serumfibroblastgrowthfactor19fgf19levelsareassociatedwithatherogenicdyslipidemiainpatientswithtype2diabetes
AT jinding serumfibroblastgrowthfactor19fgf19levelsareassociatedwithatherogenicdyslipidemiainpatientswithtype2diabetes
AT zhiguangzhou serumfibroblastgrowthfactor19fgf19levelsareassociatedwithatherogenicdyslipidemiainpatientswithtype2diabetes
AT yangxiao serumfibroblastgrowthfactor19fgf19levelsareassociatedwithatherogenicdyslipidemiainpatientswithtype2diabetes
AT ningningwang serumfibroblastgrowthfactor19fgf19levelsareassociatedwithatherogenicdyslipidemiainpatientswithtype2diabetes
_version_ 1716866240079724544

Similar Items